BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37004710)

  • 1. Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
    Karges B; Tittel SR; Bey A; Freiberg C; Klinkert C; Kordonouri O; Thiele-Schmitz S; Schröder C; Steigleder-Schweiger C; Holl RW
    Lancet Diabetes Endocrinol; 2023 May; 11(5):314-323. PubMed ID: 37004710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry.
    Kamrath C; Tittel SR; Kapellen TM; von dem Berge T; Heidtmann B; Nagl K; Menzel U; Pötzsch S; Konrad K; Holl RW
    Lancet Child Adolesc Health; 2021 Jan; 5(1):17-25. PubMed ID: 33253630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of hypoglycaemia and insulin dosage in children during the initial therapy of type 1 diabetes mellitus.
    Herbst A; Roth CL; Dost AG; Fimmers R; Holl RW
    Eur J Pediatr; 2005 Oct; 164(10):633-8. PubMed ID: 16025296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen.
    Katz ML; Volkening LK; Anderson BJ; Laffel LM
    Diabet Med; 2012 Jul; 29(7):926-32. PubMed ID: 22417321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Teo E; Hassan N; Tam W; Koh S
    Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in China: a multicentre registration study.
    Li J; Yang D; Yan J; Huang B; Zhang Y; Weng J;
    Diabetes Metab Res Rev; 2014 Sep; 30(6):497-504. PubMed ID: 24687395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    Musso G; Gambino R; Cassader M; Paschetta E
    BMJ; 2019 Apr; 365():l1328. PubMed ID: 30967375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
    Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
    Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK.
    Choudhary P; de Portu S; Arrieta A; Castañeda J; Campbell FM
    Diabet Med; 2019 Sep; 36(9):1100-1108. PubMed ID: 31134668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
    Choudhary P; Kolassa R; Keuthage W; Kroeger J; Thivolet C; Evans M; Ré R; de Portu S; Vorrink L; Shin J; Habteab A; Castañeda J; da Silva J; Cohen O;
    Lancet Diabetes Endocrinol; 2022 Oct; 10(10):720-731. PubMed ID: 36058207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.
    Peters A; Van Name MA; Thorsted BL; Piltoft JS; Tamborlane WV
    Endocr Pract; 2017 Oct; 23(10):1201-1209. PubMed ID: 28704103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.